Literature DB >> 8931916

The effect of clozapine on saliva flow rate: a pilot study.

T Rabinowitz1, F R Frankenburg, F Centorrino, J Kando.   

Abstract

This study examined the effect of clozapine on saliva flow rate. Unstimulated whole saliva was collected from 9 patients taking clozapine (dose range = 50-400 mg/day) and from 8 controls who had never used clozapine. There was no significant difference between the average saliva flow rates in the two groups (p > .10), nor was there significant correlation between saliva flow rate and daily clozapine dose (p > .10). Alternative explanations for observations or complaints of excessive salivation, drooling, or a choking feeling while taking clozapine are proposed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931916     DOI: 10.1016/S0006-3223(96)89255-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

Review 1.  Clozapine-induced sialorrhea: pathophysiology and management strategies.

Authors:  Samir Kumar Praharaj; Manu Arora; Sachin Gandotra
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

Review 2.  Pharmacological interventions for clozapine-induced hypersalivation.

Authors:  Rebecca Syed; Katie Au; Caroline Cahill; Lorna Duggan; Yanling He; Victor Udu; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

3.  Sialorrhea and aspiration pneumonia: a case study.

Authors:  Eileen Trigoboff; Jeffery Grace; Herman Szymanski; Jaspinder Bhullar; Claudia Lee; Thomas Watson
Journal:  Innov Clin Neurosci       Date:  2013-05

4.  Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.

Authors:  Shih-Yu Chen; Gopi Ravindran; Qichen Zhang; Steve Kisely; Dan Siskind
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

5.  Initiating clozapine treatment service and characteristics of clozapine-treated patients in a general hospital in Addis Ababa, Ethiopia.

Authors:  Solomon Teferra
Journal:  S Afr J Psychiatr       Date:  2020-06-24       Impact factor: 1.550

6.  Clozapine: Current perspective.

Authors:  Ram K Solanki; Paramjeet Singh; Mukesh K Swami
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

7.  Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.

Authors:  Dieter Schoepf; Hardeep Uppal; Rahul Potluri; Reinhard Heun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-13       Impact factor: 5.270

8.  A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH).

Authors:  Cecilia Livermore; Hannah White; Loren Bailey; Ian Osborne; Ebenezer Oloyede; Olubanke Dzahini; Eromona Whiskey
Journal:  BMC Psychiatry       Date:  2022-04-20       Impact factor: 4.144

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.